Iliad Biotechnologies, LLC
iliadbio.comindustry
Biotechnology · Biotechnology Research · Clinical Trials · Health Care · Pharmaceutical
Size
11 - 50 employees
Stage
Other
founded in
2012
ILiAD Biotechnologies (ILiAD) is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-attenuated pertussis vaccine that has successfully completed a Phase 1 human clinical trial. ILiAD Biotechnologies is a registered Delaware company founded in 2012.
Something looks off?Open jobs at Iliad Biotechnologies, LLC
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.